Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas

NCT01434602 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

86

Enrollment

NIH

Sponsor class

Conditions

Brain Tumor
Glioblastoma
Anaplastic Glioma

Interventions

DRUG: everolimus
DRUG: sorafenib

Sponsor

National Cancer Institute (NCI)